ACT Genomics Holdings Company Ltd.
2 known investors
ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.
Investors · 2
Competitors · 6
by search overlapLabcorp70 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
IDbyDNA55 shared keywordsScalable, high throughput DNA sequencing platforms.
American Cancer Society (ACS)54 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
MD Anderson Cancer Center40 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.
Cancerresearchuk40 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
Myriad38 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Companies competing with ACT Genomics Holdings Company Ltd. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does ACT Genomics Holdings Company Ltd. do?
- ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.
- Who are ACT Genomics Holdings Company Ltd.'s investors?
- ACT Genomics Holdings Company Ltd.'s investors include Kyoto University Innovation Capital, UMC Capital.